Valuation (71%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 11.76 | N/A |
| PEG Ratio (TTM) | 2.22 | N/A |
| P/S Ratio (TTM) | 9.15 | N/A |
| P/B Ratio (TTM) | 3.37 | N/A |
| P/FCF Ratio (TTM) | 11.33 | N/A |
| Price to 5YR AVG Earnings Ratio | 15.85 | N/A |
| Price to 5YR AVG FCF Ratio | 17.02 | N/A |
Profitability (100%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 28.19% | N/A |
| ROE (TTM) | 48.72% | N/A |
| Net Profit Margin (TTM) | 66.03% | N/A |
| ROIC 5YR AVG | 69.18% | N/A |
Growth (97%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 13.59% | 49.51% | 41.26% |
| Revenue | 10.89% | 22.06% | 28.98% |
| Net Income | 13.25% | 53.41% | 46.18% |
| Cash Flow | 9.90% | 14.58% | 29.60% |
Health (63%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 14.21 | N/A |
| Quick Ratio (TTM) | 14.21 | N/A |
| D/E Ratio (TTM) | 0.00 | N/A |
| Interest Coverage (TTM) | N/A | N/A |
| Piotroski F-Score | 5 | N/A |
| Altman Z-Score | N/A | N/A |
| LTL to 5YR AVG FCF | 0.01 | N/A |
| Shares Outstanding Growth 5YR AVG | 3.77% | N/A |